These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15648095)

  • 1. Pindolol augmentation of selective serotonin reuptake inhibitors: accounting for the variability of results of placebo-controlled double-blind studies in patients with major depression.
    Segrave R; Nathan PJ
    Hum Psychopharmacol; 2005 Apr; 20(3):163-74. PubMed ID: 15648095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interest of the use of pindolol in the treatment of depression: review].
    Brousse G; Schmitt A; Chereau I; Eschalier A; Dubray C; Llorca PM
    Encephale; 2003; 29(4 Pt 1):338-50. PubMed ID: 14615704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial.
    Perry EB; Berman RM; Sanacora G; Anand A; Lynch-Colonese K; Charney DS
    J Clin Psychiatry; 2004 Feb; 65(2):238-43. PubMed ID: 15003079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
    Pérez V; Soler J; Puigdemont D; Alvarez E; Artigas F
    Arch Gen Psychiatry; 1999 Apr; 56(4):375-9. PubMed ID: 10197835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression.
    Portella MJ; de Diego-Adeliño J; Ballesteros J; Puigdemont D; Oller S; Santos B; Álvarez E; Artigas F; Pérez V
    J Clin Psychiatry; 2011 Jul; 72(7):962-9. PubMed ID: 21034693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A short-term double-blind randomized controlled pilot trial with active or placebo pindolol in patients treated with venlafaxine for major depression.
    Martiny K; Lunde M; Bech P; Plenge P
    Nord J Psychiatry; 2012 Jun; 66(3):147-54. PubMed ID: 22458638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Réseau de Recherche et d'Expérimentation Psychopharmacologique.
    Bordet R; Thomas P; Dupuis B
    Am J Psychiatry; 1998 Oct; 155(10):1346-51. PubMed ID: 9766765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential 5-HT1A autoreceptor occupancy by pindolol is attenuated in depressed patients: effect of treatment or an endophenotype of depression?
    Rabiner EA; Bhagwagar Z; Gunn RN; Cowen PJ; Grasby PM
    Neuropsychopharmacology; 2004 Sep; 29(9):1688-98. PubMed ID: 15127080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pindolol augmentation of selective serotonin reuptake inhibitors: PET evidence that the dose used in clinical trials is too low.
    Rabiner EA; Bhagwagar Z; Gunn RN; Sargent PA; Bench CJ; Cowen PJ; Grasby PM
    Am J Psychiatry; 2001 Dec; 158(12):2080-2. PubMed ID: 11729033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paroxetine with pindolol augmentation: a double-blind, randomized, placebo-controlled study in depressed in-patients.
    Geretsegger C; Bitterlich W; Stelzig R; Stuppaeck C; Bondy B; Aichhorn W
    Eur Neuropsychopharmacol; 2008 Feb; 18(2):141-6. PubMed ID: 18054209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pindolol augmentation of antidepressant treatment: recent contributions from brain imaging studies.
    Martinez D; Broft A; Laruelle M
    Biol Psychiatry; 2000 Oct; 48(8):844-53. PubMed ID: 11063979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pindolol augmentation of serotonin reuptake inhibitors for the treatment of depressive disorder: a systematic review.
    Whale R; Terao T; Cowen P; Freemantle N; Geddes J
    J Psychopharmacol; 2010 Apr; 24(4):513-20. PubMed ID: 18832428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of pindolol to potentiate antidepressant medication.
    Blier P; Bergeron R
    J Clin Psychiatry; 1998; 59 Suppl 5():16-23; discussion 24-5. PubMed ID: 9635544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of fluoxetine's antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors.
    Pérez V; Puiigdemont D; Gilaberte I; Alvarez E; Artigas F;
    J Clin Psychopharmacol; 2001 Feb; 21(1):36-45. PubMed ID: 11199945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How long should pindolol be associated with paroxetine to improve the antidepressant response?
    Zanardi R; Artigas F; Franchini L; Sforzini L; Gasperini M; Smeraldi E; Perez J
    J Clin Psychopharmacol; 1997 Dec; 17(6):446-50. PubMed ID: 9408806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial.
    Dannon PN; Sasson Y; Hirschmann S; Iancu I; Grunhaus LJ; Zohar J
    Eur Neuropsychopharmacol; 2000 May; 10(3):165-9. PubMed ID: 10793318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment.
    Pérez V; Gilaberte I; Faries D; Alvarez E; Artigas F
    Lancet; 1997 May; 349(9065):1594-7. PubMed ID: 9174562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is pindolol augmentation effective in depressed patients resistant to selective serotonin reuptake inhibitors? A systematic review and meta-analysis.
    Liu Y; Zhou X; Zhu D; Chen J; Qin B; Zhang Y; Wang X; Yang D; Meng H; Luo Q; Xie P
    Hum Psychopharmacol; 2015 May; 30(3):132-42. PubMed ID: 25689398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An index of 5-HT synthesis changes during early antidepressant treatment: alpha-[11C]methyl-L-tryptophan PET study.
    Berney A; Nishikawa M; Benkelfat C; Debonnel G; Gobbi G; Diksic M
    Neurochem Int; 2008; 52(4-5):701-8. PubMed ID: 17928105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitchell B. Balter Award--1998. Pindolol and major affective disorders: a three-year follow-up study of 30,485 patients.
    Räsänen P; Hakko H; Tiihonen J
    J Clin Psychopharmacol; 1999 Aug; 19(4):297-302. PubMed ID: 10440455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.